pharmaphorum
JANUARY 27, 2022
Walter Greenleaf, PhD, neuroscientist and digital health expert at Stanford University’s Virtual Human Interaction Lab, tells us about the new book Applied Virtual Reality in Healthcare: Case Studies and Perspectives and why he and his co-authors gathered insights from some of the most prominent figures in the field of medical extended reality (XR).
Fierce Healthcare
JANUARY 27, 2022
MDLive rolls out virtual-first health monitoring program for chronic conditions. rtorrence. Thu, 01/27/2022 - 10:59.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Outsourcing Pharma
JANUARY 26, 2022
A leader from Elligo Health Research (a SCOPE 2022 exhibitor ) discusses flaws in traditional recruitment approaches and offers up some fresh new ideas.
Pharma Marketing Network
JANUARY 27, 2022
Tune in to the Pharma Marketing Network and industry experts Novartis, UCB, GSK and others, for a fireside talk on hot topics around what has changed in the last year and how to align your pharma marketing strategies accordingly. Three Panels: . Engaging Oncologists in 2022. Emerging Digital Channels and Navigating the Social Landscape: What’s Hot, What’s Not, What’s the Next Big Thing.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
pharmaphorum
JANUARY 28, 2022
Digital health venture funding had a ridiculous, bonkers, blockbuster year. On this, everyone can agree, although longtime watchers of the industry will remember that we’ve heard that consistently for the last several years. But never mind, 2021 was a blockbuster even compared to 2020 or 2019, with many sources saying there was twice as much, or nearly twice as much money raised this past year compared with the year before.
Fierce Healthcare
JANUARY 26, 2022
Uber taps first chief medical officer for growing healthcare arm. rtorrence. Wed, 01/26/2022 - 16:24.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
The Physician Pharmacist
JANUARY 28, 2022
This article will serve as a comprehensive guide to help you understand all the hype about the MCAT! The MCAT, also known as the Medical College Admission Test, is a critical entrance-style exam that students are required to take to be considered for a seat in a medical school. As a pharmacy student, you probably have heard of this notorious test, but know little about the finer details!
pharmaphorum
JANUARY 24, 2022
In November, NICE backed NHS use of AstraZeneca’s diabetes and heart failure drug Forxiga for the treatment of chronic kidney disease. pharmaphorum caught up with AZ’s Joris Silon to discuss unmet needs in the condition. “Many times, I have talked to nephrologists who take care of patients with chronic kidney disease in the later stages, and they have a very simple message – and that is, if we really want to do something for these patients then we need to intervene earlier,” says Joris Silon, se
Fierce Healthcare
JANUARY 26, 2022
Number of ACOs increases modestly to 483 for 2022, which advocates say should be wake-up call. rking. Wed, 01/26/2022 - 13:36.
Outsourcing Pharma
JANUARY 25, 2022
The agency has given the go-ahead on an IND application for a study evaluating Ananda Scientificâs Nantheia ATL5, a candidate for treating opioid use disorder.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharma Mirror
JANUARY 28, 2022
Singapore, Asia’s integrated healthcare company, Clearbridge Health Limite is pleased to announce that Labnovation Technologies, Inc.’s (“Labnovation”) COVID-19 Antigen Rapid (“ART”) Test Kit, which is imported by Clearbridge and registered for use in the Philippines, has been recently approved by the Food and Drug Administration (“FDA”) of the Philippines for self-testing.
pharmaphorum
JANUARY 28, 2022
Merck & Co has passed another milestone in its drive to move PD-1 inhibitor Keytruda earlier in the treatment pathway for cancer, with the European Commission approving use of the drug as post-surgery (adjuvant) therapy for renal cell carcinoma (RCC). Adjuvant treatment moves use of the drug into patients with earlier-stage cancer, a key strategy for Merck and other cancer immunotherapy companies as it expands the pool of patients eligible for treatment.
Fierce Healthcare
JANUARY 26, 2022
Senate health leaders preview bipartisan plan to overhaul the nation's public health response. dmuoio. Wed, 01/26/2022 - 12:17.
Outsourcing Pharma
JANUARY 25, 2022
Am expert from the CRO discusses unique challenges associated with running clinical trials that stretch across national boarders and how to conquer them.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharma Marketing Network
JANUARY 27, 2022
In partnership with Villanova University, Drexel University, Thomas Jefferson University, the University of the Sciences and Columbia Business School, the HBA continues to advocate for the connection between advanced education and advancement in the workplace. For Immediate Release: Philadelphia— January 18, 2022 — Today, the Mid-Atlantic Region and the Philadelphia Chapter of the Healthcare Businesswomen’s Association announced the curriculum for their Winter 2022 Master Class, a series of 5 on
pharmaphorum
JANUARY 25, 2022
The area of digital therapeutics is growing rapidly, and in this piece Ben Hargreaves examines why this is the case, how broadly these therapies can be applied and why investment in the area is mounting. To demonstrate how quickly the digital therapeutics space is developing, it is easiest to state that the first such therapy was approved in 2018 and since that point the annual investment in the space has more than doubled in the intervening years.
Fierce Healthcare
JANUARY 27, 2022
GAO calls for major reforms at HHS to better prepare for future health emergencies. rking. Thu, 01/27/2022 - 16:39.
Outsourcing Pharma
JANUARY 28, 2022
A representative from IQVIA discusses the particulars of the US agencyâs new draft document and shares what it might mean for clinical trial data evaluation.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharma Marketing Network
JANUARY 27, 2022
In partnership with Villanova University, Drexel University, Thomas Jefferson University, the University of the Sciences and Columbia Business School, the HBA continues to advocate for the connection between advanced education and advancement in the workplace. For Immediate Release: Philadelphia— January 18, 2022 — Today, the Mid-Atlantic Region and the Philadelphia Chapter of the Healthcare Businesswomen’s Association announced the curriculum for their Winter 2022 Master Class, a series of 5 on
pharmaphorum
JANUARY 24, 2022
A private equity group has agreed to take over most of IBM Watson Health, seven years after the business was launched with a pledge to revolutionise healthcare data analysis. Francisco Partners is picking up a range of databases and analytics tools – including Health Insights, MarketScan, Clinical Development, Social Programme Management, Micromedex and other imaging and radiology tools – for an undisclosed sum estimated to be in the region of $1 billion.
Fierce Healthcare
JANUARY 27, 2022
Chutes & Ladders—North Carolina HHS head joins Aledade; Uber Health adds first-ever chief medical officer. dmuoio. Thu, 01/27/2022 - 16:27.
Outsourcing Pharma
JANUARY 26, 2022
The upcoming industry event offers attendees (in-person and virtual) a range of opportunities to learn, connect, and innovate, according to an organizer.
NICE
JANUARY 26, 2022
NICE has recently published a guideline on Shared decision making (nice.org.uk) (SDM) which defines SDM as a collaborative process involving a person and their healthcare professional working together to reach a joint decision about care. In essence, the clinician provides evidence-based information using a variety of tools and techniques to describe risks and benefits and encourages the person to express their beliefs, values, and choices.
pharmaphorum
JANUARY 26, 2022
The final numbers are in, and now it’s official – digital health companies raked in a massive $57.2 billion in funding last year, beating prior records with a 79% increase over 2020. The data from CB Insights’ annual State of Digital Health report notes that the record investments were apparent across all geographies and were “fuelled by the growing need to provide digital solutions and delivery models to patients during the pandemic.” Highlights of the year included an a
Fierce Healthcare
JANUARY 25, 2022
Here's why UnitedHealth Group's CMO says virtual care is a 'game changer' to reach underserved populations. hlandi. Tue, 01/25/2022 - 16:19.
Outsourcing Pharma
JANUARY 28, 2022
In a partnership with Medable, a center at the university discovered costs linked to investing in decentralized studies far outweigh the eventual benefits.
PharmD Live
JANUARY 25, 2022
PharmDs Earn MVP Status . By Marshall Eidenberg, OD. Chronic care services managed by a doctor of pharmacy, PharmD, is a critical addition to a medical practice, but they are not widely engaged with these responsibilities. With the challenging number of diagnoses and medications that Medicare patients take, it is essential to have a team member whose primary function is to rapidly review patients records, give informed advice on any side effects to watch out for, and give medication interaction
pharmaphorum
JANUARY 25, 2022
The UK company behind a sleep mask that aims to treat sight-robbing complications of diabetes has secured $10 million in funding that will be used to run trials of the medical device. PolyPhotonix secured the money in a first-round financing led by Prevail InfoWorks, a company specialising in management of clinical trial data, with the cash injection due upon the start of a clinical trial in the US.
Fierce Healthcare
JANUARY 28, 2022
AHIP warns proposed ACA exchange rule could threaten market's growing stability. pminemyer. Fri, 01/28/2022 - 11:40.
Outsourcing Pharma
JANUARY 26, 2022
One of the finalists for the 2022 Participant Engagement Award (saluting patient recruitment and retention solution) will be announced as winner at SCOPE.
Pharma Marketing Network
JANUARY 25, 2022
The post Engaging Oncologists in 2022 appeared first on Pharma Marketing Network.
pharmaphorum
JANUARY 27, 2022
The first patient has been treated with an implantable bioelectronic device developed by Galvani Therapeutics, set up by GlaxoSmithKline and Alphabet’s Verily Life Sciences in 2016. A rheumatoid arthritis patient has become the first of five to be implanted with the wireless device in the UK study – using keyhole surgery at the NHS Greater Glasgow & Clyde Health Board in Scotland last November – in a first step towards treating chronic diseases by modifying nerve signals to organs in t
Fierce Healthcare
JANUARY 28, 2022
GAO calls for major reforms at HHS to better prepare for future health emergencies. pminemyer. Fri, 01/28/2022 - 10:15.
Expert insights. Personalized for you.
142 
Let's personalize your content